Haemoperfusion in chloroquine poisoning. 1985

R Garnier, and J Elmalem

UI MeSH Term Description Entries
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D006464 Hemoperfusion Removal of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose). Hemosorption,Hemoperfusions,Hemosorptions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Garnier, and J Elmalem
July 1983, Lancet (London, England),
R Garnier, and J Elmalem
November 1990, The International journal of artificial organs,
R Garnier, and J Elmalem
January 1981, Human toxicology,
R Garnier, and J Elmalem
December 1995, Journal of tropical pediatrics,
R Garnier, and J Elmalem
February 1978, Lancet (London, England),
R Garnier, and J Elmalem
January 1980, Lancet (London, England),
R Garnier, and J Elmalem
January 1980, Lancet (London, England),
R Garnier, and J Elmalem
February 1980, Lancet (London, England),
R Garnier, and J Elmalem
May 1985, Lancet (London, England),
R Garnier, and J Elmalem
January 1984, European journal of clinical pharmacology,
Copied contents to your clipboard!